MedTrace Logo

Longitudinal Assessment of Cardiovascular and Renal Health in Patients With Hepatitis-C (CARE-Hep C)

NCT01846494 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 113

Last updated 2019-03-22

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to monitor the cardiovascular and renal health of patients who previously took BMS-986094 (an investigational medication for hepatitis C) in comparison to hepatitis C infected patients who have never taken BMS-986094.

Conditions

  • Hepatitis C

Sponsors & Collaborators

Principal Investigators

  • Adrian F. Hernandez, MD · Duke Clinical Research Institute

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-10
Primary Completion
2018-03-19
Completion
2018-03-19

Countries

  • United States
  • Puerto Rico

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01846494 on ClinicalTrials.gov